-- Achieved Primary Endpoint with 30mg Dose of RE104 Demonstrating 23.0-Point Reduction from Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)…
Achieved alignment with the FDA on sNDA package to expand the IGALMI label for the At-Home (Outpatient) setting sNDA submission on…
Two of the region’s leading organizations team up to elevate community-based care options for seniors across Tampa Bay.TAMPA, Fla., Aug.…
Following positive preclinical data, simufilam development to advance with a clinical study expected to begin in H1 2026 for the…
Leadership continuity positions neurocare for its next decade of global expansion, innovation, and patient impact. MUNICH, DE / ACCESS Newswire…
Leadership continuity positions neurocare for its next decade of global expansion, innovation, and patient impact. MUNICH, DE / ACCESS Newswire…
Strategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductionsReporting segment formerly known as…
ST. PETERSBURG, Fla., Aug. 12, 2025 /PRNewswire/ -- Cognitive Research Corporation (CRC), a full-service CRO specializing in neuroscience, has officially…
MND combines proprietary resveratrol-based platform and NovaSOL® Curcumin to enhance cognitive performance and support neuroprotective health Jupiter, Florida, Aug. 11,…
NEW HAVEN, Conn., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence…